Cannbiorx Life Sciences Stock EBITDA
| ATNFW Stock | USD 0.01 0 34.09% |
CannBioRx Life Sciences fundamentals help investors to digest information that contributes to CannBioRx Life's financial success or failures. It also enables traders to predict the movement of CannBioRx Stock. The fundamental analysis module provides a way to measure CannBioRx Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CannBioRx Life stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -22.1 M | -23.2 M |
CannBioRx | EBITDA |
CannBioRx Life Sciences Company EBITDA Analysis
CannBioRx Life's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current CannBioRx Life EBITDA | (22.13 M) |
Most of CannBioRx Life's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CannBioRx Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
CannBioRx EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for CannBioRx Life is extremely important. It helps to project a fair market value of CannBioRx Stock properly, considering its historical fundamentals such as EBITDA. Since CannBioRx Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CannBioRx Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CannBioRx Life's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
CannBioRx Ebitda
According to the company disclosure, CannBioRx Life Sciences reported earnings before interest,tax, depreciation and amortization of (22.13 Million). This is much lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The ebitda for all United States stocks is notably higher than that of the company.
CannBioRx EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CannBioRx Life's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CannBioRx Life could also be used in its relative valuation, which is a method of valuing CannBioRx Life by comparing valuation metrics of similar companies.CannBioRx Life is currently under evaluation in ebitda category among its peers.
CannBioRx Fundamentals
| Return On Equity | -3.99 | ||||
| Return On Asset | -0.63 | ||||
| Number Of Shares Shorted | 10.74 K | ||||
| EBITDA | (22.13 M) | ||||
| Net Income | (19.94 M) | ||||
| Total Debt | 1.05 M | ||||
| Book Value Per Share | (0.24) X | ||||
| Cash Flow From Operations | (10.92 M) | ||||
| Beta | 0.25 | ||||
| Market Capitalization | 250.78 M | ||||
| Total Asset | 5.26 M | ||||
| Retained Earnings | (127.34 M) | ||||
| Working Capital | (1.42 M) | ||||
| Net Asset | 5.26 M |
About CannBioRx Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CannBioRx Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CannBioRx Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CannBioRx Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CannBioRx Stock Analysis
When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.